SpyGlass Pharma, Inc. Common Stock
- SGP
- NASDAQ
- Biotechnology
- Ophthalmic Drug Delivery
- Implantable Eye Treatment (BIM-IOL)
$26.27
Today +6.78%Quote Oct 20, 2026, 05:48 PM UTC
−15.41%over the last month
Max drawdown −18.5%From 1-month high −15.4%3 months +21.4%
Our viewPro
The call stays with Pro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
About SpyGlass Pharma, Inc. Common Stock
SpyGlass Pharma, Inc. is an advanced biopharmaceutical company dedicated to developing innovative therapeutic approaches for individuals suffering from chronic eye conditions.
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Employees
76
Market value
$878.6M
Quote Oct 20
Floor
$25.83
1.7% below price
Resistance
$26.85
2.2% above price
Price vs analyst targets
1 analyst
Lowest target
$37.00Highest target
$39.00
$37.00Highest target
$39.00
- Price $26.27
- Average target $38.00
- Analysts' target range
The price is below even the lowest analyst target. Analysts' average target sits about 45% higher.
The call stays with Pro
7 locked chapters- What to do with this namePro
- Why nowPro
- Why this stockPro
- Section write-upsPro
- Story timelinePro
- News briefPro
- Ask about SGPPro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Log in — 14 days free